What is the speaker's key advice to community physicians managing newly diagnosed AML?
Complete induction locally and refer to a transplant center only once the patient is in first complete remission.
Refer early and do molecular testing up front, so targeted therapies can be added to induction, patients can be risk-stratified for chemotherapy plus targeted therapy versus transplant, and clinical trial enrollment can be considered.
Reserve referral to a larger center for patients who relapse after standard induction chemotherapy.